Myriad Genetics | MYGN - Current Assets


Myriad Genetics reported $289M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Agilent USD 4.69B 70M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Bio-Rad Laboratories USD 3.02B 78.4M Jun/2026
Bruker USD 2.22B 121.4M Jun/2026
Danaher USD 14.79B 1.41B Sep/2026
Illumina USD 2.83B 96M Jun/2026
J&J USD 56.35B 3.42B Sep/2026
Mettler Toledo International USD 1.35B 15.48M Jun/2026
Myriad Genetics USD 289M 23.8M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Pacific Biosciences Of California USD 338.64M 30.88M Jun/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Quidel USD 1.38B 400K Jun/2026
Repligen USD 1.24B 41.43M Sep/2026
Revvity USD 2.3B 169.4M Jun/2026
Standard Biotools USD 521.45M 67.19M Mar/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Veracyte USD 574.78M 52.6M Jun/2026
Waters USD 3.9B 186M Jun/2026